Important note: Information in this article was accurate in 1987. The state of the art may have changed since the publication date.
Autologous rosette forming cells in subjects at risk for the acquired immunodeficiency syndrome.
AIDS Res. 1986 Fall;2(4):335-42. Unique Identifier : AIDSLINE MED/87128381 Cabral CM; Sen L; Palacios MF; Muchinik G; Maero EB; Scaglione C; Estevez ME
Abstract:
We investigated the distribution of autologous rosette forming cells (ARFC) in the peripheral blood from subjects at risk for the acquired immunodeficiency syndrome (AIDS). The mean percentage of ARFC with autologous plasma from 35 male homosexual individuals was significantly lower than that of 31 normal controls. The mean percentage of ARFC of SARA had a direct linear correlation with the percentage of T4+ cells (p less than 0.01). Within the SARA group, those with antibodies against HTLV-III/LAV had percentages of ARFC significantly lower than SARA with negative antibodies. Plasma from SARA decreased the percentage of ARFC of normal cells when compared to normal homologous plasma (p less than 0.005), whereas normal homologous plasma did not modify the low percentage of ARFC from SARA. These results indicate that SARA possess a depletion of this subpopulation of T cells. This is more pronounced in subjects with anti-HTLV-III/LAV antibodies. The low ARFC is related to a decrease in the number of cells that correlates with the number of T4+ cells. The inhibition of normal ARFC by plasma from SARA suggests the existence of plasma factors that could mask the lymphocyte receptors for their own red blood cells and/or coat erythrocytes preventing lymphocyte-erythrocyte binding.
Keywords: Acquired Immunodeficiency Syndrome/*IMMUNOLOGY Adult *Homosexuality Human Lymphocytes/IMMUNOLOGY Male Middle Age Risk Rosette Formation *Sex Behavior Support, Non-U.S. Gov't JOURNAL ARTICLE
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.